oxazoles has been researched along with Myocardial Ischemia in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (54.55) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bousquet, P; Catelli, M; Feldman, J; Tibirica, E | 1 |
Hong, C; Kim, SJ; Liu, J; Molina, CA; Odashima, M; Sadoshima, J; Soler, S; Thaisz, J; Vatner, DE; Vatner, SF; Yamamoto, S; Yang, G; Yatani, A; Yehia, G; Zablocki, D | 1 |
Grover, GJ; Ogletree, ML; Schumacher, WA | 1 |
Gomoll, AW; Ogletree, ML; Schumacher, WA | 1 |
Gomoll, AW; Grover, GJ; Ogletree, ML | 1 |
Armstrong, SC; Delacey, MH; Ganote, CE; Hoover, DB | 1 |
Armstrong, SC; Ganote, CE; Gao, W; Lane, JR | 1 |
Armstrong, SC; Ganote, CE; Shivell, LC | 1 |
Grover, GJ; Rosenfeld, L; Stier, CT | 1 |
Babsky, A; Bansal, N; Doliba, N; Hekmatyar, S; Osbakken, M; Wehrli, S | 1 |
Armstrong, SC; Ganote, CE | 1 |
1 review(s) available for oxazoles and Myocardial Ischemia
Article | Year |
---|---|
Ifetroban sodium: an effective TxA2/PGH2 receptor antagonist.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Humans; Hypertension; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Ischemia; Oxazoles; Platelet Aggregation Inhibitors; Prostaglandin H2; Prostaglandins H; Randomized Controlled Trials as Topic; Receptors, Prostaglandin; Receptors, Thromboxane; Stroke; Thrombosis; Thromboxane A2 | 2001 |
10 other study(ies) available for oxazoles and Myocardial Ischemia
Article | Year |
---|---|
Protective effects of centrally acting sympathomodulatory drugs on myocardial ischemia induced by sympathetic overactivity in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Electrocardiography; Female; Glutamic Acid; Heart Rate; Hemodynamics; Male; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Oxazoles; Propranolol; Rabbits; Rilmenidine; Sympathetic Nervous System | 2003 |
Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.
Topics: Alkaloids; Animals; Apoptosis; Benzophenanthridines; Cardiomegaly; Cardiomyopathy, Dilated; Caspase 3; Caspases; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Genes, Dominant; Heart Ventricles; Marine Toxins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Organ Specificity; Oxazoles; Phenanthridines; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Transduction, Genetic | 2003 |
Thromboxane receptor antagonist BMS-180291, but not aspirin, reduces the severity of pacing-induced ischemia in dogs.
Topics: Angina Pectoris; Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Pacing, Artificial; Coronary Circulation; Disease Models, Animal; Dogs; Female; Hemodynamics; Injections, Intravenous; Male; Myocardial Ischemia; Oxazoles; Propionates; Radioligand Assay; Receptors, Thromboxane | 1994 |
Dose-related cardioprotection by ifetroban in relation to inhibition of thrombosis and ex vivo platelet function.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Ferrets; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Oxazoles; Platelet Aggregation Inhibitors; Propionates; Receptors, Thromboxane; Thrombosis | 1995 |
Myocardial salvage efficacy of the thromboxane receptor antagonist ifetroban in ferrets and dogs.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Dogs; Female; Ferrets; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxazoles; Propionates; Receptors, Thromboxane | 1994 |
Translocation of PKC, protein phosphatase inhibition and preconditioning of rabbit cardiomyocytes.
Topics: Adenosine; Animals; Cells, Cultured; Heart; Isoenzymes; Marine Toxins; Myocardial Ischemia; Myocardium; Oxazoles; Phosphoprotein Phosphatases; Protein Kinase C; Rabbits; Tetradecanoylphorbol Acetate | 1996 |
Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia.
Topics: Adenosine Triphosphate; Alkenes; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Marine Toxins; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardium; Naphthalenes; Oxazoles; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Phosphorylation; Polyenes; Protein Kinase C; Pyrones; Rabbits | 1998 |
Sarcolemmal blebs and osmotic fragility as correlates of irreversible ischemic injury in preconditioned isolated rabbit cardiomyocytes.
Topics: Animals; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Enzyme Inhibitors; Heart; Hypotonic Solutions; Ischemic Preconditioning; Marine Toxins; Microscopy, Electron; Myocardial Ischemia; Myocardium; Osmotic Fragility; Oxazoles; Phosphoprotein Phosphatases; Rabbits; Sarcolemma; Time Factors; Trypan Blue | 2001 |
Influence of ischemic preconditioning on intracellular sodium, pH, and cellular energy status in isolated perfused heart.
Topics: Acidosis; Animals; Energy Metabolism; Hydrogen-Ion Concentration; Intracellular Membranes; Ischemic Preconditioning, Myocardial; Magnetic Resonance Spectroscopy; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxazoles; Perfusion; Phosphates; Phosphocreatine; Pyrimidinones; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hydrogen Exchangers | 2002 |
Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes.
Topics: Adenosine Triphosphate; Animals; Cell Survival; Ethers, Cyclic; Heart; In Vitro Techniques; Marine Toxins; Myocardial Contraction; Myocardial Ischemia; Myocardium; Okadaic Acid; Osmotic Fragility; Oxazoles; Phosphoprotein Phosphatases; Rats | 1992 |